Evoq Remedies Limited (BOM:543500)
India flag India · Delayed Price · Currency is INR
3.150
0.00 (0.00%)
At close: Feb 13, 2026

Evoq Remedies Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
7864118177307-
Market Cap Growth
-60.58%-45.94%-33.26%-42.52%--
Enterprise Value
7589130282345-
Last Close Price
3.152.568.6712.9922.60-
PE Ratio
4.6372.2726.0610.9128.17-
PS Ratio
0.190.451.870.671.83-
PB Ratio
0.180.140.470.711.33-
P/TBV Ratio
0.180.140.470.711.33-
P/FCF Ratio
2.76-2.22---
P/OCF Ratio
2.53-2.22---
EV/Sales Ratio
0.190.632.061.072.06-
EV/EBITDA Ratio
3.9650.3321.0312.33--
EV/EBIT Ratio
4.1169.5221.2812.3523.57-
EV/FCF Ratio
2.65-2.45---
Debt / Equity Ratio
--0.170.390.350.00
Debt / EBITDA Ratio
--6.854.18--
Debt / FCF Ratio
--0.80--0.04
Asset Turnover
0.820.330.180.770.811.46
Inventory Turnover
20.664.900.6113.7329.5374.41
Quick Ratio
0.621.610.161.722.800.94
Current Ratio
6.829.103.173.453.281.10
Return on Equity (ROE)
4.04%0.25%1.81%6.75%9.13%186.89%
Return on Assets (ROA)
2.30%0.18%1.06%4.19%4.42%8.71%
Return on Invested Capital (ROIC)
3.99%0.24%1.42%5.19%7.56%194.11%
Return on Capital Employed (ROCE)
4.10%0.30%2.40%9.20%6.30%128.20%
Earnings Yield
22.53%1.38%3.84%9.17%3.55%-
FCF Yield
36.28%-233.45%45.02%-24.67%-89.92%-
Buyback Yield / Dilution
-30.91%-83.09%--35.84%-900.56%-40.93%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.